INTRODUCTION
Helium is an inert, nonflammable gas that possesses the lowest density of any gas other than hydrogen. Helium was isolated from atmospheric air in 1895 by Sir William Ramsey. Its clinical applications were first mentioned by A.L. Branch in 1935 who suggested its treatment of upper airway obstructive lesions. 1, 2 Since then, helium in combination with oxygen has been used in the treatment of upper airway obstruction of various etiologies including viral and postintubation subglottic edema, laryngeal tumors, and laryngeal edema from inhalation injury. 3 -7 Later applications have demonstrated its efficacy for more distal obstructive processes including bronchospasm-related reactive airway disease in spontaneously and mechanically ventilated patients. 8 -11 Helium is an inert gas that has no direct harmful effect or interaction with human tissues. Helium has been used in both adult and pediatric patients without sequelae; however, we are unaware of previous reports concerning its use during pregnancy. There should be no direct or indirect toxic effects on either the mother or the fetus. We report the use of mechanical ventilation with a helium-oxygen mixture during respiratory failure related to status asthmaticus in a 15-year-old girl during the second trimester of an intrauterine pregnancy.
CASE REPORT
A 15-year-old girl with a second trimester intrauterine pregnancy was transferred to our institution for treatment of status asthmaticus. Gestational age was estimated to be 22 weeks. She had a previous history of asthma that was controlled with a combination of inhaled corticosteroids and bronchodilators. Two days before admission, she presented to another hospital's emergency department (ED) with shortness of breath. At that time she received a prescription for amoxicillin and was discharged home. One day before admission she experienced increased shortness of breath. She was using her albuterol meter dose inhaler every 20 minutes with minimal improvement and returned to the other ED for further evaluation with complaints of pleuritic chest pain, clear rhinorrhea, sore throat, and watery eyes. Initial therapy included albuterol through high flow nebulization, intravenous ampicillin, and methylprednisolone.
Significant past medical history included asthma diagnosed at 6 months of age. She had multiple previous exacerbations and hospitalizations, but no prior history of ICU admission or endotracheal intubation. She smoked 20 cigarettes per day for the last 3 years. Outpatient medications included prenatal vitamins, amoxicillin, inhaled corticosteroids, and albuterol metered dose inhaler (MDI). She had no known allergies. Family history was negative for hypercoaguable states, deep venous thrombosis, or pulmonary embolism. The pregnancy had been uncomplicated until the ED visits.
Following transfer to our institution, she was treated with albuterol high flow nebulization every 2 to 3 hours and intravenous methylprednisolone. Arterial blood gas while breathing 50% oxygen through a facemask revealed a PaO 2 of 57.5 mm Hg, a PaCO 2 of 30.9 mm Hg, and a pH of 7.38. Due to the lack of improvement, a respiratory rate of 50 to 60 breaths/minute and an increased oxygen requirement, she was
transferred to the pediatric ICU (PICU) for further management. In the PICU, continuous albuterol high flow nebulization was started at 15 mg/hr with ipratroprium 500 g every 3 hours, intravenous methylprednisolone every 6 hours, and magnesium sulfate 2 g intravenously every 6 hours. Antibiotic therapy was changed to piperacillin/tazobactam and azithromycin. On day 1 of admission to the PICU, the patient was requiring an F i O 2 of 1.0 to maintain an oxygen saturation of 94%. Due to persistent bronchoconstriction, intravenous terbutaline was started and increased up to 0.35 g/kg per minute. Despite the use of noninvasive ventilatory support with bilevel positive airway pressure (BiPAP) through a facemask using our previously described technique.
12
, the patient developed progressive respiratory failure and required endotracheal intubation on hospital day 4. Mechanical ventilation was provided in the time-cycled, pressure-limited mode using a Servo 900C ventilator (Siemens, Stockholm, Sweden). Sedation was provided by continuous infusion of midazolam and fentanyl and neuromuscular blockade provided by a cisatracurium infusion for the first 4 days of mechanical ventilation. Bronchoscopy was performed following endotracheal intubation to obtain specimens for culture (bacterial, viral, acid fast, fungal, pneumocystis, and legionella species). Following endotracheal intubation, chest radiographs progressively worsened with an increasing alveolar infiltrate consistent with adult respiratory distress syndrome (ARDS). The initial 24 hours of mechanical ventilation included a combination of air and oxygen with an F i O 2 of 0.8 to 1.O and peak inflating pressures of 38 to 40 cm H 2 O. Oxygen saturation varied from 94% to 96%. Despite various manipulations in the inspiratory to expiratory ratio, respiratory rate, and peak inflating pressure, there was progressive hypercapnia with transcutaneous/arterial CO 2 values of 55 to 65 mm Hg. After discussion of potential risks/benefits and obtaining of verbal consent from the patient's mother, mechanical ventilation was switched to a heliumoxygen mixture using our previously described technique (see below). 13 With the switch to mechanical ventilation with heliox, no other changes were made of the ventilatory settings. The concentration of helium was increased as tolerated to maintain an oxygen saturation of >93%. The patient was able to tolerate mixtures of 25% helium in oxygen during the first 2 to 3 hours. This was increased to 40% and then to 55% to 60% helium in oxygen over the next 4 to 6 hours. During this time, there was a decrease in the transcutaneous/arterial CO 2 to 35 to 40 mm Hg without a significant change in the oxygen saturation despite the fact that the F i O 2 had decreased to 0.35 to 0.4. Daily fetal heart tone measurements were performed to determine the status of the fetus. During the course of mechanical ventilation, additional therapy included albuterol MDI, ipratroprium MDI, intravenous methylprednisolone, and a continuous intravenous infusion of terbutaline. Over the ensuing 8 days, there was a progressive improvement in her respiratory status as demonstrated by a decrease in ventilatory (decreased pressure) and oxygen requirements. Neuromuscular blockade was discontinued and sedation decreased to allow for a gradual weaning of mechanical ventilatory support. She was extubated after 8 days of mechanical ventilation. Following extubation, albuterol was administered through continuous nebulization at 15 mg/hr using a mixture of helium (60% to 70%) in oxygen. The patient's respiratory status continued to improve, the therapy for her reactive airway disease was gradually weaned, and she was discharged home 17 days after admission and 5 days after extubation. The patient went on to deliver a healthy, full term, male infant. At 1 year, both the mother and infant are doing well.
DISCUSSION
The beneficial effects of a helium-oxygen mixture derive from its lower density when compared to either 100% oxygen or any concentration of oxygen in air-nitrogen. During turbulent gas flow, resistance to gas flow is directly proportional to the density of the gas and inversely proportional to the radius to the fourth power as described by Poiseuille's law (Table 1) . With severe bronchospasm, although therapy is primarily directed at relieving bronchospasm and increasing the radius of the airways, this effect may take hours to days to accomplish. The effect of lowering the density of the inhaled gas with the use of a helium-oxygen mixture can be achieved within minutes thereby allowing for decreased resistance to gas flow, improved gas exchange, and decreased peak inflating pressures.
In addition to decreasing resistance, administration of a gas mixture with a lower density and higher viscosity may improve gas flow by converting turbulent flow to laminar flow. With bronchospasm and airway narrowing, areas that normally manifest laminar flow may develop turbulent flow thereby decreasing gas flow. The Reynolds number is the ratio of kinetic and viscous forces (Table 1) . It is calculated as two times the product of the radius, the average velocity of gas flow, and the density of the gas divided by the viscosity of the gas. It can be used to determine whether flow will be laminar or turbulent with turbulent flow occurring when the Reynolds number exceeds 2000. With the substitution of helium for nitrogen, the Reynolds number may decrease and turbulent flow may become laminar thereby further decreasing resistance to gas flow. These effects may be particularly prominent in the more distal areas of the airway where flow is generally laminar during the normal state. However, Reynolds number = 2rv / y , density of gas; L, length of tube; r, radius of tube; v, average velocity of gas flow; y, viscosity of gas.
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Helium-Oxygen Mixture for Mechanical Ventilation pathologic conditions can result in turbulent flow further compromising ventilatory function. Despite this potential for beneficial effects, there remains limited experience with the use of helium-oxygen mixtures in adult and pediatric populations with status asthmaticus. Kass and Castriotta. 9 evaluated the therapeutic efficacy of helium-oxygen breathing in 12 adult patients with status asthmaticus and respiratory acidosis (PaCO 2 >45 mm Hg), five of whom were receiving mechanical ventilation. With the administration of helium, there was a decrease in the PaCO 2 from 57.9±8.3 to 47.5±4.3 mm Hg and an increase in the pH from 7.23±0.07 to 7.32±0.04. In patients with status asthmaticus, requiring mechanical ventilation, Gluck et al. 11 reported a decrease in the peak inflating pressure from a mean of 86 to 53 cm H 2 O and a decrease in the PaCO 2 from a mean of 87 to 51 Torr. The change in PIP was noted early (2.5 minutes) whereas the maximal decrease in PaCO 2 required 22.2 minutes. Similar results have been reported by other investigators. 10, 13 In addition to its use during mechanical ventilation, other investigators have reported the potential beneficial effects of helium during status asthmaticus with spontaneous ventilation. Manthous and colleagues.
14 demonstrated a more rapid and greater improvement of peak expiratory flow rates and decreased pulsus paradoxus in patients receiving conventional therapy while breathing a heliumoxygen mixture compared to a control group breathing an air/ oxygen mixture. Anderson et al. 15 demonstrated a more distal delivery into the airways of aerosolized medications using a helium-oxygen carrier gas compared to air/oxygen.
Status asthmaticus during pregnancy presents several unique issues and problems. 16 Pregnancy alters normal respiratory mechanics and function. The increased abdominal pressure decreases functional residual capacity thereby increasing resistance and decreasing compliance during the resting state. The mother also has to adapt to increased metabolic demands and increased carbon dioxide production. During pregnancy, especially the second and third trimesters, patients who develop status asthmaticus are more likely to develop respiratory failure than nonpregnant patients. 16 Additionally, treatment of status asthmaticus during pregnancy can be particularly problematic as it is desirable to maintain a lower PaCO 2 to preserve uterine blood. This is compounded by the fact that the normal PaCO 2 is 32 mm Hg during the second and third trimesters. Maternal acidosis can lead to fetal acidosis with secondary effects including fetal distress and preterm labor. Therefore, permissive hypercapnia, commonly practiced during respiratory failure in the nonpregnant state, may not be safe during pregnancy thereby further increasing the demands of mechanical ventilation and therefore the risks of iatrogenic lung injury. In fact, there are no data concerning the use or safety of permissive hypercapnia during pregnancy.
During the initial period of mechanical ventilation in our patient, the PaCO 2 varied from 55 to 60 mm Hg. Although this value is generally considered acceptable (as long as the pH is >7.25) with the current use of permissive hypercapnia, hypercarbia to this degree can have significant deleterious on uterine blood flow. There are no studies demonstrating the safety of permissive hypercapnia during pregnancy. As the peak inflating pressure was already 40 cm H 2 O, we felt that options other than increasing the PIP were indicated. Based on previous successes with this form of therapy, we initiated mechanical ventilation with a helium-oxygen mixture in this patient.
We report for the first time the use of a helium-oxygen mixture for mechanical ventilation during pregnancy. By improving gas flow and decreasing resistance, use of a helium-oxygen mixture may improve respiratory function as well as limit the iatrogenic consequences of mechanical ventilation. Several logistic issues must be considered before the use of helium-oxygen mixtures during either spontaneous or controlled ventilation. 13, 17 The switch from air/ oxygen to helium-oxygen is recommended as a potential therapeutic strategy when effective ventilation cannot be achieved or when peak inflating pressures are such that the potential for iatrogenic lung injury exists. 18 As helium has no direct therapeutic effects, other therapies aimed at the primary disease process are required. As helium is an inert gas, has no direct interaction with living tissues, and is not taken up by the body across the respiratory tract, it can be expected to have no toxic effects to either the mother or the fetus. However, until further data and clinical experience are available, we suggest that informed consent should be obtained before its use.
